移植卵巢组织生育力保存与再冷冻:管理恶性细胞复发低风险患者的潜在新方法
本文报告一例23岁1C期卵巢黏液性囊腺癌患者,冻存卵巢组织9年后行异位移植,成功经体外受精获双胎妊娠。出于安全考虑腹腔镜取出移植组织并再冷冻,异种移植4周后显示卵泡存活,卵泡分布较新鲜组织向生长阶段偏移。患者随后进入绝经,两块残余移植组织学评估共见5个卵泡。
要点
- 移植卵巢组织取出后再冷冻成功,异种移植4周后显示卵泡存活。
- 回收移植组织中卵泡分布较新鲜组织向生长阶段偏移。
- 较少的功能性卵泡即可支持卵巢功能,再冷冻或为低复发风险患者的新选择。
核心结论
- 这是异位移植后分娩的第二例,也是早期卵巢癌患者卵巢组织成功移植的第二例。
- 回收的移植组织显示,比先前估计更少的功能性卵泡即可支持卵巢功能。
- 取出并再冷冻移植组织可能是处理有恶性细胞复发风险患者及某些遗传性疾病患者的新方法。
研究设计与样本
- 对冻存并移植的卵巢组织进行冷冻保存与移植后再冷冻评估。
- 地点为大学医院。
- 患者为23岁女性,诊断为1C期卵巢黏液性囊腺癌。
主要发现
- 患者冻存卵巢组织9年后行异位移植以恢复生育力。
- 成功经体外受精获双胎妊娠后,出于安全考虑腹腔镜取出移植组织。
- 回收组织再冷冻后,异种移植4周显示卵泡存活。
- 回收移植组织中卵泡分布较新鲜组织向生长阶段偏移。
- 患者随后进入绝经,两块残余移植组织学评估共见5个卵泡,这些组织数月前尚支持卵巢功能。
临床怎么用
- 作者认为,取出并再冷冻移植组织可能是处理有恶性细胞复发风险患者及某些遗传性疾病患者的新方法。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To report the first successful refreezing of ovarian tissue recovered more than 3 years after transplantation in a woman previously treated for early-stage ovarian cancer. DESIGN: Evaluation of cryopreserved and grafted ovarian tissue. SETTING: University hospital. PATIENT(S): A 23-year-old woman diagnosed with stage 1C ovarian mucinous cystadenocarcinoma. INTERVENTION(S): The patient underwent ovarian tissue cryopreservation for fertility preservation and subsequent heterotopic transplantation for fertility restoration 9 years after freezing. After a successful IVF twin pregnancy, grafted tissue was laparoscopically removed for safety reasons. The recovered tissue was refrozen. MAIN OUTCOME MEASURE(S): Live birth and histologic evaluation of the distribution of pre-antral follicle stages. RESULT(S): The previously grafted ovarian tissue was successfully refrozen, presenting follicular survival 4 weeks after xenografting. The follicular distribution in the recovered grafts showed a shift toward growing-stage follicles compared with the fresh tissue. The patient subsequently entered menopause, and histologic evaluation revealed a total of five follicles in two remaining grafts which had supported ovarian function a few months earlier. CONCLUSION(S): This is the second case of delivery following heterotopic grafting as well as the second case of successful transplantation of ovarian tissue from a patient with early-stage ovarian cancer. The recovered grafts showed that a lower number of functional follicles than previously estimated can actually support ovarian function. Removing and refreezing grafted tissue could be a new way of handling not only cancer patients with a risk of malignant cell recurrence, but also certain groups of patients with genetic conditions.
引用
- Kristensen SG, Giorgione V, Humaidan P, et al. Fertility preservation and refreezing of transplanted ovarian tissue-a potential new way of managing patients with low risk of malignant cell recurrence. Fertil Steril. 2017. PMID: 28433369. doi:10.1016/j.fertnstert.2017.03.017
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。